Report cover image

Global Red biotechnology Market 2024-2028

Publisher TechNavio
Published Dec 05, 2023
Length 166 Pages
SKU # INF18379635

Description

Global Red Biotechnology Market 2024-2028


The red biotechnology market is forecasted to grow by USD 174.56 bn during 2023-2028, accelerating at a CAGR of 6.23% during the forecast period. The report on the red biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in genomic research, an increase in the prevalence of chronic diseases, and a growing aging population globally.

Technavio's red biotechnology market is segmented as below:

By Product
  • Monoclonal antibodies
  • Gene therapy
  • Polyclonal antibodies
  • Cell-based immunotherapy products
  • Others
By End-user
  • Pharmaceutical and biotechnology companies
  • CMOs and CROs
  • Academic research institutes
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising stem cell research and therapies as one of the prime reasons driving the red biotechnology market growth during the next few years. Also, the increasing production of biopharmaceuticals and therapeutic proteins and the rising prevalence of bioinformatics and data analytics will lead to sizable demand in the market.

The report on the red biotechnology market covers the following areas:
  • Red biotechnology market sizing
  • Red biotechnology market forecast
  • Red biotechnology market industry analysis
The robust vendor analysis is designed to help clients improve their market position. In line with this, this report provides a detailed analysis of several leading red biotechnology market vendors that include Amgen Inc., Astellas Pharma Inc., AstraZeneca Plc, Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Bruker Corp., CRISPR Therapeutics AG, Editas Medicine Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Merck KGaA, Mesoblast Ltd., Moderna Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., STEMCELL Technologies Inc., and Teva Pharmaceutical Industries Ltd.. Also, the red biotechnology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

166 Pages
    • Market overview
    • Market ecosystem
    • Market definition
    • Market segment analysis
    • Market size 2023
    • Market outlook: Forecast for 2023-2028
    • Global red biotechnology market 2018 - 2022
    • Product Segment Analysis 2018 - 2022
    • End-user Segment Analysis 2018 - 2022
    • Geography Segment Analysis 2018 - 2022
    • Country Segment Analysis 2018 - 2022
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
    • Market segments
    • Comparison by Product
    • Monoclonal antibodies - Market size and forecast 2023- 2028
    • Gene therapy - Market size and forecast 2023-2028
    • Polyclonal antibodies - Market size and forecast 2023- 2028
    • Cell-based immunotherapy products - Market size and forecast 2023-2028
    • Others - Market size and forecast 2023-2028
    • Market opportunity by Product
    • Market segments
    • Comparison by End-user
    • Pharmaceutical and biotechnology companies – Market size and forecast 2023-2028
    • CMOs and CROs - Market size and forecast 2023-2028
    • Academic research institutes - Market size and forecast 2023-2028
    • Market opportunity by End-user
    • Customer landscape overview
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2023-2028
    • Europe - Market size and forecast 2023-2028
    • Asia - Market size and forecast 2023-2028
    • Rest of World (ROW) - Market size and forecast 2023- 2028
    • US - Market size and forecast 2023-2028
    • China - Market size and forecast 2023-2028
    • UK - Market size and forecast 2023-2028
    • Canada - Market size and forecast 2023-2028
    • Germany - Market size and forecast 2023-2028
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Impact of drivers and challenges
    • Market trends
    • Overview
    • Vendor landscape
    • Landscape disruption
    • Industry risks
    • Vendors covered
    • Market positioning of vendors
    • Amgen Inc.
    • Astellas Pharma Inc.
    • AstraZeneca Plc
    • Bayer AG
    • Biogen Inc.
    • Boehringer Ingelheim International GmbH
    • Bristol Myers Squibb Co.
    • Bruker Corp.
    • F. Hoffmann La Roche Ltd.
    • Gilead Sciences Inc.
    • Merck KGaA
    • Pfizer Inc.
    • Regeneron Pharmaceuticals Inc.
    • STEMCELL Technologies Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Scope of the report
    • Inclusions and exclusions checklist
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us